$HQY
HEALTHEQUITY, INC. Stock $hqy

$hqy Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000142833617000014 Filed on June 08, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$55.42M	$44.01M
YoY Change	25.92%	47.45%
Cost Of Revenue	$21.68M	$16.33M
YoY Change	32.75%	36.74%
Gross Profit	$33.74M	$27.68M
YoY Change	21.89%	54.59%
Gross Profit Margin	60.88%	62.89%
Selling, General & Admin	$10.49M	$8.757M
YoY Change	19.78%	46.17%
% of Gross Profit	31.09%	31.64%
Research & Development	$6.242M	$4.625M
YoY Change	34.96%	31.24%
% of Gross Profit	18.5%	16.71%
Depreciation & Amortization	$3.482M	$2.947M
YoY Change	18.15%	68.4%
% of Gross Profit	10.32%	10.65%
Operating Expenses	$17.81M	$14.43M
YoY Change	23.44%	45.42%
Operating Profit	$15.93M	$13.25M
YoY Change	20.2%	66.0%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$90.00K	-$641.0K
YoY Change	-85.96%	510.48%
Pretax Income	$15.84M	$12.61M
YoY Change	25.6%	60.07%
Income Tax	$1.808M	$4.536M
% Of Pretax Income	11.42%	35.97%
Net Earnings	$14.03M	$8.073M
YoY Change	73.78%	62.21%
Net Earnings / Revenue	25.31%	18.34%
Basic Earnings Per Share	$0.23	$0.14
Diluted Earnings Per Share	$0.23	$0.14
COMMON SHARES
Basic Shares Outstanding	59.72M shares	57.82M shares
Diluted Shares Outstanding	61.40M shares	59.40M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$195.6M	$132.9M
YoY Change	47.18%	15.67%
Cash & Equivalents	$155.1M	$92.77M
Short-Term Investments	$40.50M	$40.20M
Other Short-Term Assets	$4.100M	$6.300M
YoY Change	-34.92%	50.0%
Inventory	$529.0K	$598.0K
Prepaid Expenses	$4.069M	$6.300M
Receivables	$18.99M	$15.71M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$219.1M	$155.5M
YoY Change	40.9%	19.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.083M	$3.388M
YoY Change	79.55%	10.04%
Goodwill	$4.651M	$4.651M
YoY Change	0.0%	0.0%
Intangibles	$64.68M	$66.45M
YoY Change	-2.67%	149.66%
Long-Term Investments	$206.0K	$281.0K
YoY Change	-26.69%	-6.33%
Other Assets	$1.851M	$1.874M
YoY Change	-1.23%	183.08%
Total Long-Term Assets	$83.71M	$76.71M
YoY Change	9.12%	119.11%
TOTAL ASSETS
Total Short-Term Assets	$219.1M	$155.5M
Total Long-Term Assets	$83.71M	$76.71M
Total Assets	$302.8M	$232.2M
YoY Change	30.4%	40.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.545M	$1.226M
YoY Change	26.02%	23.84%
Accrued Expenses	$4.435M	$3.146M
YoY Change	40.97%	46.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$10.31M	$6.975M
YoY Change	47.74%	34.55%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.700M	$800.0K
YoY Change	112.5%	60.0%
Total Long-Term Liabilities	$1.700M	$2.530M
YoY Change	-32.81%	-54.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.31M	$6.975M
Total Long-Term Liabilities	$1.700M	$2.530M
Total Liabilities	$12.01M	$9.505M
YoY Change	26.3%	-11.28%
SHAREHOLDERS EQUITY
Retained Earnings	$52.08M	$11.68M
YoY Change	345.78%	-245.53%
Common Stock	$6.000K	$6.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$290.8M	$222.7M
YoY Change
Total Liabilities & Shareholders Equity	$302.8M	$232.2M
YoY Change	30.4%	40.51%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	$14.03M	$8.073M
YoY Change	73.78%	62.21%
Depreciation, Depletion And Amortization	$3.482M	$2.947M
YoY Change	18.15%	68.4%
Cash From Operating Activities	$15.58M	$2.112M
YoY Change	637.5%	19.25%
INVESTING ACTIVITIES
Capital Expenditures	$1.437M	$321.0K
YoY Change	347.66%	-61.14%
Acquisitions
YoY Change
Other Investing Activities	-$100.0K	-$100.0K
YoY Change	0.0%	-99.75%
Cash From Investing Activities	-$4.274M	-$2.410M
YoY Change	77.34%	-94.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.829M	$9.423M
YoY Change	-59.37%	113.0%
NET CHANGE
Cash From Operating Activities	$15.58M	$2.112M
Cash From Investing Activities	-$4.274M	-$2.410M
Cash From Financing Activities	$3.829M	$9.423M
Net Change In Cash	$15.13M	$9.125M
YoY Change	65.82%	-125.25%
FREE CASH FLOW
Cash From Operating Activities	$15.58M	$2.112M
Capital Expenditures	$1.437M	$321.0K
Free Cash Flow	$14.14M	$1.791M
YoY Change	689.45%	89.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2017Q2	dei	Document Period End Date DocumentPeriodEndDate	2017-04-30
CY2017Q2	dei	Document Type DocumentType	10-Q
CY2017Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001428336
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	59973713	shares
CY2017Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q2	dei	Entity Registrant Name EntityRegistrantName	HEALTHEQUITY INC
CY2016Q2	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	1049000	USD
CY2017Q2	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	1083000	USD
CY2017Q1	hqy	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	180359000	USD
CY2017Q2	hqy	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	195557000	USD
CY2017Q2	hqy	Cost Method Investment Ownership Percentage CostMethodInvestmentOwnershipPercentage	0.02
CY2016Q2	hqy	Cost Of Services Card Costs CostOfServicesCardCosts	2719000	USD
CY2017Q2	hqy	Cost Of Services Card Costs CostOfServicesCardCosts	3304000	USD
CY2017Q2	dei	Amendment Flag AmendmentFlag	false
CY2017Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2017Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q2	hqy	Cost Of Services Custodial Costs CostOfServicesCustodialCosts	2356000	USD
CY2017Q2	hqy	Cost Of Services Custodial Costs CostOfServicesCustodialCosts	2801000	USD
CY2017Q2	hqy	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	3900000	USD
CY2016Q2	hqy	Other Expenses Agreements OtherExpensesAgreements	60000	USD
CY2017Q2	hqy	Other Expenses Agreements OtherExpensesAgreements	120000	USD
CY2017Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised	0.10
CY2017Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Forfeited ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited	24.36
CY2017Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Granted ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitGranted	41.28
CY2017Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
CY2017Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
CY2017Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised	33.47
CY2017Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Forfeited ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited	44.53
CY2017Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Granted ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitGranted	46.40
CY2017Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	44.53
CY2017Q2	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	46.40
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3221000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1545000	USD
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17001000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18988000	USD
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3760000	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4435000	USD
CY2017Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6013000	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6645000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-165000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-191000	USD
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	232114000	USD
CY2017Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	238953000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1822000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3010000	USD
CY2017Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	75000	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	75000	USD
CY2016Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	18000	USD
CY2017Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	41000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2500000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2800000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1600000	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	583000	shares
CY2017Q1	us-gaap	Assets Assets	279136000	USD
CY2017Q2	us-gaap	Assets Assets	302849000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	200819000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	219143000	USD
CY2017Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	40405000	USD
CY2017Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	40472000	USD
CY2017Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	207000	USD
CY2017Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	232000	USD
CY2017Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	472000	USD
CY2017Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	539000	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	332000	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	207000	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	25362000	USD
CY2017Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	15110000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	15359000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	15110000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	40472000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	40779000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	25420000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	25362000	USD
CY2016Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8000	USD
CY2017Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	133000	USD
CY2016Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	1900000	USD
CY2017Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2200000	USD
CY2017Q1	us-gaap	Inventory Net InventoryNet	592000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	529000	USD
CY2016Q2	us-gaap	Investment Advisory Management And Administrative Fees InvestmentAdvisoryManagementAndAdministrativeFees	13811000	USD
CY2017Q2	us-gaap	Investment Advisory Management And Administrative Fees InvestmentAdvisoryManagementAndAdministrativeFees	19319000	USD
CY2016Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	593000	USD
CY2017Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1100000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	17196000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	12005000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	279136000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	302849000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	17814000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	13250000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	15927000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1861000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	83641000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92766000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	139954000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	155085000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	139954000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	155085000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9125000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	15131000	USD
CY2017Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	180624000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	195864000	USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59538000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59904000	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59538000	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59904000	shares
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2017Q2	us-gaap	Cost Method Investments CostMethodInvestments	500000	USD
CY2016Q2	us-gaap	Cost Of Services CostOfServices	16332000	USD
CY2017Q2	us-gaap	Cost Of Services CostOfServices	21680000	USD
CY2016Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	34000	USD
CY2017Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3218000	USD
CY2017Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1456000	USD
CY2017Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1700000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	1615000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	6438000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	37000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
CY2016Q2	us-gaap	Depreciation Depreciation	447000	USD
CY2017Q2	us-gaap	Depreciation Depreciation	632000	USD
CY2016Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2947000	USD
CY2017Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3482000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.360
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.114
CY2017Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.248
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8722000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15703000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10305000	USD
CY2017Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1493000	USD
CY2017Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1700000	USD
CY2016Q2	us-gaap	Membership Dues Revenue On Going MembershipDuesRevenueOnGoing	18994000	USD
CY2017Q2	us-gaap	Membership Dues Revenue On Going MembershipDuesRevenueOnGoing	22487000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9423000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3829000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2410000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4274000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2112000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15576000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	8073000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	14029000	USD
CY2016Q2	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	111000	USD
CY2017Q2	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	141000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-641000	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-90000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	14431000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1851000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-39000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-26000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	8034000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	14003000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-641000	USD
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4325000	USD
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	23200000	USD
CY2017Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.22
CY2017Q2	us-gaap	Equity Method Investments EquityMethodInvestments	206000	USD
CY2016Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	9278000	USD
CY2017Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2016Q2	us-gaap	Fees And Commissions Credit And Debit Cards FeesAndCommissionsCreditAndDebitCards	11208000	USD
CY2017Q2	us-gaap	Fees And Commissions Credit And Debit Cards FeesAndCommissionsCreditAndDebitCards	13615000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	30908000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	33758000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	95928000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	98441000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	65020000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	64683000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4574000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5868000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	4651000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	4651000	USD
CY2016Q2	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2017Q2	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	27681000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	33741000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12609000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15837000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4536000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1808000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1241000	USD
CY2017Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1545000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1398000	USD
CY2017Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1987000	USD
CY2016Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1164000	USD
CY2017Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	625000	USD
CY2016Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-5173000	USD
CY2017Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4397000	USD
CY2016Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-22000	USD
CY2017Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-63000	USD
CY2016Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	583000	USD
CY2017Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	244000	USD
CY2016Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4739000	USD
CY2017Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1207000	USD
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1579000	shares
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1680000	shares
CY2017Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	65020000	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	64683000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-90000	USD
CY2016Q2	us-gaap	Payments For Software PaymentsForSoftware	2003000	USD
CY2017Q2	us-gaap	Payments For Software PaymentsForSoftware	2728000	USD
CY2016Q2	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	86000	USD
CY2017Q2	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	109000	USD
CY2016Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	321000	USD
CY2017Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1437000	USD
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2867000	USD
CY2017Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4069000	USD
CY2016Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	145000	USD
CY2017Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3829000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11183000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12728000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5170000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6083000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4625000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6242000	USD
CY2016Q2	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	2100000	USD
CY2017Q2	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	2800000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	29985000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	52076000	USD
CY2016Q2	us-gaap	Revenues Revenues	44013000	USD
CY2017Q2	us-gaap	Revenues Revenues	55421000	USD
CY2016Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4183000	USD
CY2017Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4621000	USD
CY2016Q2	us-gaap	Service Management Costs ServiceManagementCosts	11257000	USD
CY2017Q2	us-gaap	Service Management Costs ServiceManagementCosts	15575000	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1822000	USD
CY2017Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3010000	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.3837
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.3801
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.3829
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.3790
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0152
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0207
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0133
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0190
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.94
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	32.70
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	55000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	370000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	131529000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	116002000	USD
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4716000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4665000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.36
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.65
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	112687000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1626000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4478000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	20.36
CY2017Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.45
CY2017Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	41.61
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	54616000	USD
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y6M15D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M6D
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M23D
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y8M12D
CY2017Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	366000	shares
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	261940000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	290844000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	674000	USD
CY2017Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	741000	USD
CY2017Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	622000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59399000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61400000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57820000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59720000	shares

Files In Submission

Name	View Source	Status
0001428336-17-000014-index-headers.html	Edgar Link	pending
0001428336-17-000014-index.html	Edgar Link	pending
0001428336-17-000014.txt	Edgar Link	pending
0001428336-17-000014-xbrl.zip	Edgar Link	pending
exhibit101-firstamendmentt.htm	Edgar Link	pending
exhibit102-secondamendment.htm	Edgar Link	pending
exhibit211listofsubs.htm	Edgar Link	pending
exhibit3112017-04x30.htm	Edgar Link	pending
exhibit3122017-04x30.htm	Edgar Link	pending
exhibit3212017-04x30.htm	Edgar Link	pending
exhibit3222017-04x30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hqy-20170430.xml	Edgar Link	completed
hqy-20170430.xsd	Edgar Link	pending
hqy-20170430_cal.xml	Edgar Link	unprocessable
hqy-20170430_def.xml	Edgar Link	unprocessable
hqy-20170430_lab.xml	Edgar Link	unprocessable
hqy-20170430_pre.xml	Edgar Link	unprocessable
hqy-2017x04x3010q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HQY
HEALTHEQUITY, INC. Stock $hqy

2017 Q2 Form 10-Q Financial Statement

#000142833617000014 Filed on June 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY HEALTHEQUITY, INC. Stock $hqy

2017 Q2 Form 10-Q Financial Statement

#000142833617000014 Filed on June 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY
HEALTHEQUITY, INC. Stock $hqy